Neuroscience Market - Size, Share and Growth Analysis 2018-2026

Neuroscience Market - Size, Share and Growth Analysis 2018-2026

Neuroscience is the study of structure and function of nervous system which covers activities such as measurement and imaging of the brain activity. Neuroscience is widely used for better understanding of pathophysiology and symptoms for chronic neurological disease such as epilepsy, Alzheimer disease and other dementias. Various hardware components such as CT scan, magnetic resonance imaging (MRI), microscopes, and recording and stimulation solutions are used to perform various research activity that include, investigating neural activity, disease modeling, safety and toxicity studies, and drug discovery.

Market Dynamics

High prevalence of chronic neurological diseases leads to increasing research activities in the field of neuroscience, which in turn is expected to boost growth of the neuroscience market. For instance, according to the Centers for Disease Control and Prevention’s (CDC) factsheet in 2018, on an average, every 40 seconds someone in the U.S. has a stroke. According to CDC’s factsheet in 2018, the annual cost of stroke-related treatment is around US$ 34 billion in the U.S., which includes cost of healthcare services, medicine, and human capital cost. Similarly, The European Union incurs costs of US$ 51.4 billion, annually due to stroke and around 50% of the costs include follow up care cost and potential human capital loss to economy.

Key features of the study:

• This report provides in-depth analysis of the global neuroscience market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, pipeline analysis, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global neuroscience market based on the following parameters – company overview, financial performance, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include, Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Inc., Newport Corporation, Plexon Inc., Noldus Information Technology, Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, product up-gradation, market expansion, and marketing tactics
• The global neuroscience market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the neuroscience market

Detailed Segmentation:

• Global Neuroscience Market, By Component:
• Instrument
• Software
• Services
• Global Neuroscience Market, By End User:
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• Global Neuroscience Market, By Geography:
• North America
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• U.S.
• Canada
• Latin America
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Component
• Instrument
• Software
• Services
• By End User
• Hospital
• Diagnostic Laboratories
• Research Institutes
• Academic Institutes
• By Country:
• South Africa
• Central Africa
• North Africa
• Company
• Alpha Omega, Inc.*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
• GE Healthcare
• Axion Biosystems, Inc.
• Siemens Healthineers
• Blackrock Microsystems LLC
• Femtonics Ltd.
• Intan Technologies
• LaVision Biotec GmbH
• Mediso Medical Imaging Systems
• Neuralynx Inc
• NeuroNexus Technologies, Inc.
• Newport Corporation
• Plexon Inc.
• Scientifica Ltd.
• Sutter Instrument Corporation

“*” marked represents similar segmentation in other categories in the respective section.